US FDA clears Avaxia IND for ulcerative colitis therapy
The bovine anti-tumor necrosis factor polyclonal antibody is based on Avaxia’s oral antibody platform and is thus directly delivered to the GI tract where the inflammation occurs. Company
WellSpan Health and Johns Hopkins Medicine have renewed their oncology collaboration, aiming to widen patient access to advanced care, clinical expertise, and research initiatives throughout central Pennsylvania, US.
The LifeMap Discovery platform provides data-mining capabilities and bioinformatics applications as well as integrates embryonic development and stem cell biology with molecular, cellular, anatomical, and disease-related information. In
As part of the alliance, the companies will employ their respective technologies to constitute diverse lantipeptide-based libraries. Under the alliance, MorphoSys will also license the LanthioPep technology for